🔗 Visit the ClinicalTrials.gov page for NCT01380145
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. | Oncoimmunology | 2012 | 1.88 |
| 2 | Trial watch: Peptide vaccines in cancer therapy. | Oncoimmunology | 2012 | 1.17 |
| 3 | Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis. | Spermatogenesis | 2011 | 1.16 |
| 4 | Cancer/testis antigens and urological malignancies. | Nat Rev Urol | 2012 | 1.01 |
| 5 | Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma. | Bone Marrow Transplant | 2015 | 0.89 |
| 6 | Development of Novel Immunotherapies for Multiple Myeloma. | Int J Mol Sci | 2016 | 0.82 |
| 7 | The Role of Immunotherapy in Multiple Myeloma. | Pharmaceuticals (Basel) | 2016 | 0.77 |
| 8 | Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015. | J Transl Med | 2016 | 0.77 |